In this application are proposed experiments aimed at a better understanding of the breast cancer suppression function of the tumor suppressor gene product, BRCA1. In particular, we have found that the protein plays a significant role in the processes that allow post-mitotic chromatin to replicate in the next S phase, and the proposal describes experiments using Xenopus BRCA1 that are aimed at understanding the biochemical basis for this phenomenon. Furthermore, the BRCA1 gene is large and encodes multiple, alternatively spliced mRNAs. The product of one of them, a 1399 residue chromatin associated protein called IRIS is of special interest. Unlike the full length BRCA1 protein, p220, IRIS appears to facilitate S phase progression, and the proposal describes experiments aimed at understanding how this function is performed and also at whether IRIS plays a role in the evolution of certain BRCA1 -/- human tumors. Finally, we have discovered a novel DNA helicase, BACH1, as a directly interacting BRCAl-associated partner protein. BACH1/BRCA1 complex formation is essential for the development of proper double strand break repair in cells exposed to ionizing radiation, and it may well be the product of a human cancer gene in its own right. The proposal is aimed at a better understanding of how BACH 1 functions in vivo and at gaining insights into the possibility that BACH1 operates as a breast cancer suppressing element through its interaction with BRCA1.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA080111-08
Application #
7221171
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2006-02-01
Budget End
2007-01-31
Support Year
8
Fiscal Year
2006
Total Cost
$483,949
Indirect Cost
Name
Whitehead Institute for Biomedical Research
Department
Type
DUNS #
120989983
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Li, Andrew G; Murphy, Elizabeth C; Culhane, Aedin C et al. (2018) BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1? activation. Proc Natl Acad Sci U S A 115:E9600-E9609
Wu, Yanming; Zhang, Zhao; Cenciarini, Mauro E et al. (2018) Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2-ER?-GREB1 Transcriptional Axis. Cancer Res 78:671-684
Witwicki, Robert M; Ekram, Muhammad B; Qiu, Xintao et al. (2018) TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer. Cell Rep 25:1255-1267.e5
Jeselsohn, Rinath; Bergholz, Johann S; Pun, Matthew et al. (2018) Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations. Cancer Cell 33:173-186.e5
Hinohara, Kunihiko; Wu, Hua-Jun; Vigneau, Sébastien et al. (2018) KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance. Cancer Cell 34:939-953.e9
Wan, Lixin; Xu, Kexin; Wei, Yongkun et al. (2018) Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function. Mol Cell 69:279-291.e5
Xiao, Tengfei; Li, Wei; Wang, Xiaoqing et al. (2018) Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy. Proc Natl Acad Sci U S A 115:7869-7878
Zhang, Jinfang; Bu, Xia; Wang, Haizhen et al. (2018) Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. Nature 553:91-95
Dreijerink, Koen M A; Timmers, H T Marc; Brown, Myles (2017) Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1. Endocr Relat Cancer 24:T135-T145
Rashidian, Mohammad; Ingram, Jessica R; Dougan, Michael et al. (2017) Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells. J Exp Med 214:2243-2255

Showing the most recent 10 out of 136 publications